[1]欧阳平 吕安康.地尔硫?对冠脉内支架术后胸痛患者的疗效[J].介入放射学杂志,2006,(05):261-263.
 OU Yang-ping,LV An-kang.[J].journal interventional radiology,2006,(05):261-263.
点击复制

地尔硫?对冠脉内支架术后胸痛患者的疗效()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2006年05期
页码:
261-263
栏目:
心脏介入
出版日期:
2006-03-01

文章信息/Info

作者:
欧阳平 吕安康
欧阳平,OUYANG Ping(201600,上海市松江区中心医院心内科)吕安康,L(U) An-kang(上海交通大学医学院附属瑞金医院心内科)
Author(s):
OU Yang-pingLV An-kang
关键词:
冠脉内支架 胸痛 严重心脏事件 再狭窄 地尔硫?
分类号:
R541.4
摘要:
目的评价地尔硫?对冠脉内支架术后胸痛患者的近期疗效和远期再狭窄的影响.方法 冠脉内支架术后胸痛患者251例,其中地尔硫(艹卓)治疗189例(75.3%),其余62例(24.7%)未接受地尔硫?治疗.比较两组随访期严重心脏事件(死亡、心肌梗死和重复靶血管再通治疗)和再狭窄率.结果在中位数128 d的随访期内,严重心脏事件在地尔硫?组为4.8%,非地尔硫?组为12.9%(P=0.039).42.6%患者于1年内行血管造影随访,地尔硫?组的再狭窄发生率显著降低(11.5%和29.2

参考文献/References:

[1]Kini AS.Lee P.Mitre CA Postprocedure chest pain after coronary stenting:implications on clinical restenosis [J]Am J Cardiol,2003,41:33—38.
[2]Versaci F.Gaspardone A.Tomai F Chest pain after coronary artery stent implantation[J] ..AmJ Cardiol,2002,89:500—504.
[3] Kaku B,HoninIK,Horita Y,et a1.The incidence of stent-edge 8p船m after stent implalltation in patiems witll or without vasospastic aIlgina pectoIis[J].Int Hean J,2005,46:23-33.
[4] Gulbenkian s,BarrosoCP,CunhaeSM,et a1.The peptider.舀c innenration of human comnary aIld cerebml vessels[J]. Ital J Anat Embryol,1995,100(Suppll):317—327.
[5] Abaci A,09uzhanA,T0psakal R,et a1.Intmcomnar)r electmcar dio铲锄 and an百na pectoris during percutaIleous coronary intenrentions as an assessmem of myocardial viability: compaIison谢th low—dose dobutamine eehocardiogmphy[J]. CatheterC盯diovasc Interv,2003,60:469—476.
[6]Jorgensen B,naulow E.E圩ects of arnlodipine onischerIlia mer percut粕eous t砌sluIIlinal coronary aIlgi叩l器ty: secondary results of the Corona巧 An舀叩l踮ty Amlodipine Restenosis (CAPARES)Study[J].Am HeanJ,2003,145:1030一1035.
[7] HobergE.ne effects 0f calcium antagonists mer门CA[J].Eur Hean J,1995,16(SupplH):9-12.
[8] Dai H,Chen J,Tao Q,et a1.Efkcts of dilti犯em on platelet activation and cytosolic calcium during percutaneous transluminal coronaryan舀叩lasty[J]. P0stgrad Med J, 2003, 79:522.526.
[9]Kuchulakanti P,Wal smaIl R.nempeutic potemial 0f oral a工lti- proliferative agents in the prevention of comnary restenosis[J]. Dmgs,2004,64:2379—2388.
[10]Voisard R,Koschniek s,Baur R,et a1.High—dose dilti∞em prevents mi铲ation aIld pmlifbration of vascular smoo山muscle cells in v枷ousin—vitr0 modelsof human eomnaryrestenosis[J]. Comn Artery Dis,1997,8:189—201_

备注/Memo

备注/Memo:
(收稿日期:2005-05—25)
更新日期/Last Update: 2010-11-19